GlassScriptPhysician profile
Matthew Crosby
NPI 1760824338
$1,686.51
in general payments reported to CMS, 2019-2025
18 companies · $38.99 in 2025
The $38.99 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $363 · 2021: $244 · 2022: $148 · 2023: $384 · 2024: $95.13 · 2025: $38.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $632.62 | 2019-2025 | |
| Genzyme Corporation | $160.32 | 2020-2023 | |
| Janssen Scientific Affairs, LLC | $148.85 | 2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $125.05 | 2020 | |
| Janssen Biotech, INC. | $88.54 | 2022-2023 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $87.11 | 2019-2024 | Dupixent |
| Leo Pharma INC. | $63.30 | 2023 | Adbry |
| Sun Pharmaceutical Industries INC. | $61.10 | 2022-2023 | Blu-U |
| E.R. Squibb & Sons, L.L.C. | $58.37 | 2023 | Sotyktu |
| Strata Skin Sciences, INC. | $58.10 | 2023-2024 | Xtrac |
| Amgen INC. | $47.10 | 2021-2024 | Otezla |
| Dusa Pharmaceuticals, INC. | $44.05 | 2019 | |
| Misonix INC | $28.19 | 2020-2021 | |
| Ucb, INC. | $21.77 | 2021 | |
| Organogenesis INC. | $17.52 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.43 | 2019 | |
| Lilly USA, LLC | $13.85 | 2024 | Taltz |
| Kyowa Kirin, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Crosby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.